CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Positron Emission Tomography–Computed Tomography versus Computed Tomography for Patients with Infective Endocarditis: Clinical Utility, Cost-Effectiveness, and Diagnostic Accuracy

Last updated: October 13, 2020
Project Number: RA1140-000
Product Line: Rapid Response
Research Type: Device
Report Type: Reference List
Result type: Report

Question

  1. What is the clinical utility of positron emission tomography–computed tomography compared to computed tomography in patients with suspected infective endocarditis or infection of cardiac devices?
  2. What is the cost-effectiveness of positron emission tomography–computed tomography compared to computed tomography in patients with suspected infective endocarditis or infection of cardiac devices?
  3. What is the diagnostic accuracy of positron emission tomography–computed tomography in patients with suspected infective endocarditis or infection of cardiac devices? 

Key Message

​Seven systematic reviews with meta-analyses and 26 non-randomized studies were identified regarding the diagnostic accuracy of positron emission tomography–computed tomography (PET-CT) in patients with suspected infective endocarditis or infection of cardiac devices. No relevant literature was identified regarding the clinical utility or cost-effectiveness of PET-CT compared to computed tomography (CT) in patients with suspected infective endocarditis or infection of cardiac devices.